"Oculus Research is a patient focused clinical research company. We were founded in 2012 and are based in Garner, North Carolina. Our research studies encompass all ages from young children to geriatric patients. We specialize in ophthalmic research studies, including glaucoma/ocular hypertension, adenoviral and bacterial conjunctivitis, blepharitis, keratoconjunctivitis sicca (dry eye), myopia control, presbyopia, and devices such as contact lenses."

During the past decade, Oculus Research conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Oculus Research" are "Adenoviral Conjunctivitis" (1 trials) and "Myopia" (1 trials). Many other conditions were trialed in "Oculus Research" in a lesser frequency.

Most popular intervention types in "Oculus Research" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atropine 0.01% Ophthalmic Solution" (1 trials), "Atropine 0.1% Ophthalmic Solution" (1 trials), "PVP-I 0.6%" (1 trials), "Placebo" (1 trials) and "Placebo Ophthalmic Solution" (1 trials). Other intervention names were less common.

The vast majority of trials in "Oculus Research" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Oculus Research". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Oculus Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Oculus Research, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".